Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06320015 · ClinicalTrials.gov registry record

Emergency Medicine Peer Outreach Worker Engagement for Recovery

A clinical trial of Opioid Use Disorder and Alcohol Use Disorder, sponsored by University of California, Los Angeles.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT06320015: Recruiting study of Opioid Use Disorder and Alcohol Use Disorder, sponsored by University of California, Los Angeles.

NCT06320015 is a study of Opioid Use Disorder and Alcohol Use Disorder that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 400 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06320015, a study of Opioid Use Disorder and Alcohol Use Disorder, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

This is an observational, prospective case-control study evaluating the effects of an emergency department community health worker-peer recovery specialist program (PCHW), the Substance Misuse Assistance Response Team (SMART). Aims of this study are to 1) understand participant experiences working with a SMART PCHW and identify possible mechanisms for successful recovery linkage; 2) Evaluate SMART effectiveness on patient-centered outcomes, building recovery capital, and recovery linkage; 3) Evaluate SMART implementation and effectiveness on patient outcomes over time. Using a combination of surveys and data linkages to state administrative databases, study investigators will prospectively compare changes in addiction treatment engagement, recovery capital, health related social needs, acute care utilization, and death between people receiving a ED PCHW and those who do not. After consenting to study participation, participants will complete surveys at time of study enrollment and 3 and 6 months after their initial ED visit. Primary outcomes include engagement in addiction treatment, social services engagement, acute care utilization, and mortality will be assessed through linkages to state administrative databases.

Primary Outcome

Investigators will measure engagement in formal addiction treatment at a state licensed addiction treatment facility and/or receipt of office-based buprenorphine through data linkages to the Rhode Island Prescription Drug Monitoring Program database and the Rhode Island Behavioral Health Online Database.

Interventions

  • OTHER Usual Care Group
  • BEHAVIORAL Substance Misuse Assistance Response Team (SMART)

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-07-01
Est. Completion 2026-10

What NCT06320015 shows while recruiting

NCT06320015 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (91% lower).

The record links to 4 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Group is the first listed.

NCT06320015 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06320015 about?

NCT06320015 is a clinical study titled "Emergency Medicine Peer Outreach Worker Engagement for Recovery". This is an observational, prospective case-control study evaluating the effects of an emergency department community health worker-peer recovery specialist program (PCHW), the Substance Misuse Assistance Response Team (SMART). Aims of this study are to 1) understand participant experiences working w...

What is the current status of trial NCT06320015?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2024-07-01. Estimated completion is 2026-10.

What conditions does trial NCT06320015 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Alcohol Use Disorder, Substance Use Disorders, Overdose.

What interventions are being tested in trial NCT06320015?

The interventions under investigation include: Usual Care Group (OTHER), Substance Misuse Assistance Response Team (SMART) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06320015?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06320015 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06320015's enrollment target sits among peer trials

400 45th of 257 higher than 212 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06320015, the US trial registry maintained by the National Library of Medicine. NCT06320015 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.